PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 14,523 Value ($000) $803 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 13,340 Value ($000) $645 Avg Close $41.90 Range $33.70 - $60.60
Q2 2024
Shares 68,231 Value ($000) $2,364 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 109,330 Value ($000) $3,163 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 106,154 Value ($000) $2,434 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 136,268 Value ($000) $2,273 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 67,094 Value ($000) $1,853 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 108,473 Value ($000) $2,495 Avg Close $16.79 Range $10.62 - $25.69
Q3 2022
Shares 232,820 Value ($000) $1,963,000 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 219,820 Value ($000) $1,739,000 Avg Close $12.09 Range $6.91 - $25.76